Unravel Global Clinical Complexities in Head and Neck Cancers: Identifying Approaches to Improve Outcomes with Manageable Toxicities - a podcast by ReachMD

CME credits: 0.25

Valid until: 29-12-2022

Claim your CME credit at https://reachmd.com/programs/cme/unravel-global-clinical-complexities-in-head-and-neck-cancers-identifying-approaches-to-improve-outcomes-with-manageable-toxicities/13056/

Formulating individualized treatment plans for patients with recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN) is increasingly essential and increasingly complex. Newer regimens have become the standard of care because of their efficacy in overall survival and reduced toxicities. So how do we deploy them now that they’re in our treatment armamentarium?

Join Drs. Joël Guigay and Kevin Harrington as they explore the role of IO as the standard of care in SCCHN and discuss the potential of taxanes to reduce dependence on fluorouracil-based chemotherapeutic regimens. Tune in to make sure you’re meeting the needs of your patients’ with SCCHN.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD